Bristol-Myers Squibb Company Ce

General ticker "CELG-RI" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $122.0B (TTM average)

Bristol-Myers Squibb Company Ce follows the US Stock Market performance with the rate: 18.9%.

Estimated limits based on current volatility of 16.5%: low 0.11$, high 0.16$

Factors to consider:

  • Total employees count: 32500 (-4.7%) as of 2025
  • US accounted for 69.1% of revenue in the fiscal year ended 2025-12-31
  • Top business risk factors: Pricing pressure, R&D failure, Regulatory and compliance, Operational and conduct risks, Supply chain disruptions
  • Current price 45.4% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [0.05$, 0.11$]
  • 2026-12-31 to 2027-12-31 estimated range: [0.07$, 0.14$]

Similar symbols

Short-term CELG-RI quotes

Long-term CELG-RI plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $45,006.00MM $47,407.00MM $47,520.00MM
Operating Expenses $36,811.00MM $55,786.00MM $38,192.00MM
Operating Income $8,195.00MM $-8,379.00MM $9,328.00MM
Non-Operating Income $245.00MM $0.00MM $0.00MM
Interest Expense $1,166.00MM $1,947.00MM $1,891.00MM
R&D Expense $9,299.00MM $11,159.00MM $9,951.00MM
Income(Loss) $8,440.00MM $-8,379.00MM $9,328.00MM
Taxes $400.00MM $554.00MM $2,272.00MM
Net Income(Loss)* $8,025.00MM $-8,948.00MM $7,054.00MM
Stockholders Equity $29,430.00MM $16,335.00MM $18,473.00MM
Inventory $2,662.00MM $2,557.00MM $2,690.00MM
Assets $95,159.00MM $92,603.00MM $90,038.00MM
Operating Cash Flow $13,860.00MM $15,190.00MM $14,156.00MM
Capital expenditure $1,209.00MM $1,248.00MM $1,311.00MM
Investing Cash Flow $-2,295.00MM $-21,352.00MM $-4,132.00MM
Financing Cash Flow $-9,416.00MM $5,127.00MM $-10,348.00MM
Earnings Per Share** $3.88 $-4.41 $3.46

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.